LifeMD Investors With Significant Losses Can Step Up in Securities Fraud Case

LifeMD Securities Fraud Lawsuit: Opportunities for Investors

LifeMD, Inc., a public company trading on NASDAQ under the ticker symbol LFMD, is currently facing serious legal challenges. The Rosen Law Firm, a leading global advocate for investor rights, has issued a crucial reminder for investors who purchased LifeMD's securities during the class period from May 7, 2025, to August 5, 2025. If you experienced losses over $50,000 during this period, you may have the chance to lead a securities fraud lawsuit initiated by the firm.

Importance of the October 27, 2025 Deadline

The deadline for investors wishing to serve as lead plaintiffs in this significant lawsuit is fast approaching on October 27, 2025. Acting as a lead plaintiff not only provides individuals with the opportunity to represent other affected shareholders but also helps guide the litigation process. It is essential that potential lead plaintiffs act swiftly to ensure their voices are heard in this critical financial matter.

No Out-of-Pocket Fees for Investors

Rosen Law Firm emphasizes that investors need not worry about upfront legal fees when joining the class action suit. The firm operates on a contingency fee basis, meaning legal costs are only incurred if the case is successful. This makes it accessible for affected investors to seek justice and potential compensation without financial pressure.

What Investors Should Know

The lawsuit alleges that during the class period, LifeMD made materially false and misleading statements regarding its business operations and market position. Investors were adversely impacted as the company reportedly overstated its competitive advantages and misrepresented customer acquisition costs associated with its RexMD segment, along with drugs for obesity treatment, specifically mentioning Wegovy and Zepbound.

These misleading statements contributed to inflated stock values, and as the truth emerged, investors faced significant financial losses. The lawsuit seeks to hold LifeMD accountable for these misrepresentations and seek recourse for those harmed by them.

Steps to Join the Class Action

Those interested in participating in the class action can do so by visiting the Rosen Law Firm's website at rosenlegal.com and submitting a form specifically designed for this case. Alternatively, investors can contact Phillip Kim, Esq. toll-free at 866-767-3653 or email him directly at [email protected].

However, it is important to understand that a class has not yet been certified. Until that occurs, individuals are not formally represented by legal counsel unless they decide to hire an attorney. Investors can remain passive members of the class if they choose, but this may affect their ability to share in future potential recoveries.

Choosing the Right Legal Counsel

It's critical for investors to select legal representation that is well-versed in handling securities class actions. Rosen Law Firm has a proven track record, having secured substantial settlements in the past and being recognized for its leadership role in investor advocacy. The firm encourages investors to be discerning when choosing their legal counsel, as not all firms have the necessary expertise to effectively litigate these types of cases.

Final Thoughts

This is a pivotal moment for affected investors of LifeMD. With the deadline approaching for involvement in the class action lawsuit, taking action may lead to potential financial recovery. For those who suffered losses exceeding $50,000, leading this lawsuit could provide a platform for accountability and a chance to reclaim losses suffered due to alleged corporate misconduct.

Follow the Rosen Law Firm on LinkedIn or Twitter for updates on legal proceedings and more information regarding this case. As the situation develops, staying informed is essential for all investors to navigate their options moving forward.